In-silico studies of Momordica charantia extracts as potential candidates against SARS-CoV-2 targeting human main protease enzyme (M^pro).

ABSTRACT: Momordica charintia, a well-known plant called bitter melon, has been shown to have antibacterial, anti-diabetic, and antiviral properties against HIV infection. The goal of this work was to investigate the inhibitory effect of phytocompounds found in Momordica charintia leaf extracts on SARS-CoV-2 3CL protease (also known as the Main protease, M^pro) utilizing GC-MS analysis and molecular docking studies. The Crystal Structure of the SARS-CoV-2 3CL protease in complex with an inhibitor N3 was downloaded from RCSB using PDB ID 6LU7 with resolution: 2.16 Å. In the present study, in silico molecular docking analysis of phytoconstituents present in M. charantia methanolic leaf extract detected by GC-MS was studied against SARS-CoV-2 M^pro. The results

SUBMITTER: Adedayo A 

PROVIDER: S-EPMC10008047 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature